Adverse event reporting tool for sedation

Authors

  • James A Roelofse

Abstract

Sedation practice today is experiencing revolutionary changes. One of them is a re-evaluation of what is defined as an adverse event during sedation. The World Health Organization (WHO) and the US Food and Drug Administration (FDA) have provided existing definitions of what an adverse event constitutes. The question is: as sedation practitioners, do these definitions provide us with any value?

Author Biography

James A Roelofse

Professor, and Head of Sedation and Pain Control University of the Western Cape Cape Town

Downloads

Additional Files

Issue

Section

SASA Refresher Text